We lack fundamental understanding of how phage infection influences bacterial gene expression and, consequently, how bacterial responses to phage infection affect the assembly of polymicrobial communities. Using parallel genomic approaches, we have discovered novel transcriptional regulators and metabolic genes that influence phage infection. The integration of whole-genome transcriptomic profiling during phage infection has revealed the differential regulation of genes important for group behaviors and polymicrobial interactions. Our work suggests that therapeutic phages could more broadly influence bacterial community composition outside their intended host targets.
KEYWORDS: bacteriophages, Enterococcus, antibiotic resistance, transposons, RNA-Seq, Tn-Seq, phage-bacterium interactions
ABSTRACT
Bacteriophages (phages) have been proposed as alternative therapeutics for the treatment of multidrug-resistant bacterial infections. However, there are major gaps in our understanding of the molecular events in bacterial cells that control how bacteria respond to phage predation. Using the model organism Enterococcus faecalis, we used two distinct genomic approaches, namely, transposon library screening and RNA sequencing, to investigate the interaction of E. faecalis with a virulent phage. We discovered that a transcription factor encoding a LytR family response regulator controls the expression of enterococcal polysaccharide antigen (epa) genes that are involved in phage infection and bacterial fitness. In addition, we discovered that DNA mismatch repair mutants rapidly evolve phage adsorption deficiencies, underpinning a molecular basis for epa mutation during phage infection. Transcriptomic profiling of phage-infected E. faecalis revealed broad transcriptional changes influencing viral replication and progeny burst size. We also demonstrate that phage infection alters the expression of bacterial genes associated with intra- and interbacterial interactions, including genes involved in quorum sensing and polymicrobial competition. Together, our results suggest that phage predation has the potential to influence complex microbial behavior and may dictate how bacteria respond to external environmental stimuli. These responses could have collateral effects (positive or negative) on microbial communities, such as the host microbiota, during phage therapy.
INTRODUCTION
Enterococcus faecalis is a member of the healthy human intestinal microbiota (1). E. faecalis is also a pathobiont that rapidly outgrows upon antibiotic-mediated intestinal dysbiosis to cause disease. E. faecalis is associated with nosocomial sepsis, endocarditis, surgical-site, urinary tract, and mixed bacterial infections (2, 3). Since the 1980s, enterococci have been evolving extensive drug resistance, including resistance to vancomycin and “last-line-of-defense” antibiotics (4–10). In addition, E. faecalis can disseminate antibiotic resistance traits to diverse bacteria, including other clinically relevant pathogens (11–17). There is an urgent need for new therapeutics that target drug-resistant enterococci.
Bacteriophages (phages) are viruses that infect bacteria. Phages are being considered for the treatment of multidrug-resistant (MDR) bacterial infections, including enterococcal infections. Recent studies have demonstrated the potential for phage-based therapies against systemic and biofilm-associated enterococcal infections (18–22). The decolonization of intestinal MDR E. faecalis may be achieved through the action of phage predation which selects for cell wall variants that are rendered sensitive to antibiotic therapy (23). However, a potential barrier to the widespread use of phage therapy against E. faecalis is the development of phage resistance. To confront this issue, we must understand the molecular mechanisms used by phages to infect E. faecalis and how E. faecalis overcomes phage infection to become resistant. Only then can this biology be exploited to develop phage therapies that mitigate the risk of developing phage resistance.
The study of phage-bacterium interactions has provided key insights into phage infection that could lead to the development of novel antibacterial therapies. Phages replicate in bacteria by hijacking the host cellular machinery to produce phage progeny. To exploit host cell resources, many phages encode auxiliary proteins which are not directly involved in phage genome replication or particle assembly but can modulate bacterial physiology to favor phage propagation (24, 25). The characterization of phage auxiliary proteins may yield tools for curtailing bacterial infections. Additionally, the discovery of phage-modulated host pathways could reveal potential therapeutic targets. Our understanding of bacterial cellular responses during phage infection is limited to transcriptomic analyses in Gram-negative bacteria, whereas Gram-positive genera are understudied (26–31). Therefore, to fill this gap and further define the molecular underpinnings of enterococcal-phage interactions, we have taken a global genomics approach to identify enterococcal factors critical for productive infection by the lytic phage VPE25 (32). To identify bacterial genes essential for VPE25 infection, we screened a low-complexity transposon (Tn)-mutant library of E. faecalis OG1RF for phage resistance (33). In addition to the VPE25 receptor (32), transposon sequencing revealed novel E. faecalis genes necessary for phage adsorption and optimum intracellular phage DNA replication and transcription. To gain deeper insights into the physiological response of E. faecalis during phage infection, we used temporal transcriptomics of a VPE25 infection cycle. Transcriptomics revealed that VPE25 infection altered the expression of diverse genes involved in protein translation, metabolism, bacterial community sensing, virulence, and biofilm formation. Our work shows that E. faecalis reprograms transcription toward stress adaptation in response to phage infection. This suggests that phages may impact the behavior of bacteria in polymicrobial communities, including bystanders that are not the intended targets of phage therapy.
RESULTS
Transposon sequencing identifies novel genes involved in phage infection of E. faecalis.
To identify genetic determinants that confer phage resistance in E. faecalis, an E. faecalis OG1RF transposon library consisting of 6,829 unique mutants was screened by sequence-defined mariner technology transposon sequencing (SMarT Tn-Seq) (33). A total of 107 CFUs of a logarithmically growing E. faecalis Tn-Seq library pool was plated on solid medium in the absence or presence of phage VPE25 at a multiplicity of infection (MOI) of 0.1. Cells from the input library prior to plating and cells plated onto plates containing no phage were used as controls. Tn insertions in E. faecalis genomic DNA were sequenced as described by Dale et al. (33). Sequencing reads were mapped to the E. faecalis OG1RF genome to identify bacterial mutants with altered phage sensitivity. The relative abundance of 22 E. faecalis mutants was enriched (adjusted P value of <0.05; log2 fold change, >0) in the presence of VPE25 relative to cultures that lacked phage and the input library (see Table S1 in the supplemental material; Fig. 1A). Five of the 22 phage-resistant enriched mutants harbored Tn insertions in OG1RF_10588 (Table S1; Fig. 1A), which was previously identified to encode the VPE25 receptor Phage Infection Protein of E. faecalis (PipEF) (32). This indicates that the Tn mutant library is an appropriate tool for the discovery of genes involved in phage infection of E. faecalis.
To gain further insight into the genetic factors that influence E. faecalis susceptibility to VPE25, we analyzed several Tn mutants, including OG1RF_10820 (lytR), OG1RF_10951 (cscK), OG1RF_12241 (lysR), OG1RF_12435, and three enterococcal polysaccharide antigen (Epa)-associated genes, OG1RF_11715 (epaOX), OG1RF_11714, and OG1RF_11710. (Table S1; Fig. 1A). epaOX and OG1RF_11714 are both annotated as glycosyltransferases. We renamed OG1RF_11714 epaOX2 as it resides downstream of epaOX. We have designated OG1RF_11710 as epaOY based on its homology to epaY (EF2169) in E. faecalis V583.
The epa genes encode proteins involved in the formation of a cell surface-associated rhamnose-containing polysaccharide (34). We and others have previously demonstrated that enterococcal phages unrelated to VPE25 utilize Epa to adsorb and infect E. faecalis (23, 35–37). Initial work from our group showed that mutation of the VPE25 receptor PipEF prevented VPE25 DNA entry into E. faecalis V583; yet, phages could still adsorb to receptor mutants (32), suggesting that the factors that promote phage infection via surface adsorption remained to be identified. Here, we show that either an in-frame deletion of epaOX (38) or Tn insertions in epaOX, epaOX2, and epaOY confer phage resistance to VPE25, similar to the pipEF receptor mutant (Fig. 1B). Mutations in pipEF, epaOX, and epaOX2 abolished VPE25 infection, while disruption of epaOY significantly reduced phage susceptibility, as determined by efficiency of plating assays (Fig. 1C). To assess the role of Epa during VPE25 infection, we investigated the ability of VPE25 to adsorb to wild-type E. faecalis, the epaOX deletion mutant, or the three epa Tn insertion mutants. Both the wild-type and the pipEF mutant strain adsorbed significantly larger amounts of VPE25 than the epa mutants (Fig. 1D). Together, these data indicate that epa-derived cell wall modifications contribute to VPE25 infection by promoting surface adsorption. This is consistent with previous observations in other lactic acid bacteria showing phage infection is a two-step process; first, phages must reversibly bind to a cell wall polysaccharide, followed by the committed initiation of DNA ejection into the cell (39–41).
In addition to epa genes, several Tn mutants whose roles during phage infection were unknown were enriched on VPE25-containing agar compared with uninfected controls (Table S1; Fig. 1A), and this included OG1RF_10820-Tn, cscK-Tn, and OG1RF_12241-Tn. OG1RF_10820 encodes a putative LytR response regulator. Orthologs of this protein control multiple cellular processes, including virulence, extracellular polysaccharide biosynthesis, quorum sensing, competence, and bacteriocin production (42). OG1RF_12241 is a homolog of the hypR (EF2958) gene of E. faecalis strain JH2-2 and encodes a LysR family transcriptional regulator. HypR regulates oxidative stress through the ahpCF (alkyl hydroperoxide reductase) operon conferring increased survival in mouse peritoneal macrophages (43, 44). Finally, CscK is a fructose kinase that converts fructose to fructose-6-phosphate for entry into glycolysis (45). Considering that these genes had never previously been shown to be associated with phage infection, we asked how Tn disruption of these genes influenced phage sensitivity using a time course phage infection assay. In the presence of phages, the optical density of the Tn mutants OG1RF_10820-Tn (lytR), cscK-Tn, and OG1RF_12241-Tn (lysR) was constant over time, whereas the growth of the wild type and the pipEF receptor mutant declined or increased over the course of infection, respectively (Fig. 2A and B). Complementation of the Tn mutants with wild-type alleles restored phage susceptibility without altering their growth in the absence of phages (see Fig. S1A, B, and C in the supplemental material). To further investigate this phage tolerance phenotype, we asked whether these mutants harbored a defect in phage production. Assessment of the number of phage particles produced during infection showed that OG1RF_10820-Tn (lytR), cscK-Tn, and OG1RF_12241-Tn (lysR) strains produced 10-fold lower phage particles than the wild-type strain (Fig. 2C), indicating that the Tn mutants have a defect in phage burst size. In the absence of phage, wild-type, ΔpipEF, OG1RF_10820-Tn (lytR), cscK-Tn, and OG1RF_12241-Tn (lysR) strains showed similar growth kinetics (Fig. 2D), indicating that these mutations do not impair growth in laboratory media. These data show that deficiencies in transcriptional signaling and metabolism have a strong impact on lytic phage production in E. faecalis.
Since we observed that OG1RF_10820-Tn, cscK-Tn, and OG1RF_12241-Tn (lysR) mutants had a reduced phage burst, releasing fewer viral particles relative to the wild type, we queried the status of viral transcription and replication in these mutants. Whole-genome transcriptomic analysis of phage-infected E. faecalis OG1RF cells indicated that the VPE25 genes orf76, orf111, and orf106 are highly expressed throughout the course of phage infection (see Table S2A in the supplemental material). However, the transcripts of these genes were less abundant in the Tn mutants OG1RF_10820-Tn (lytR), cscK-Tn, and OG1RF_12241-Tn (lysR) (see Fig. S2A in the supplemental material). Additionally, phage DNA replication is delayed in these Tn insertion mutants, as judged by significantly lower copy numbers of phage DNA relative to the wild-type strain (Fig. S2B). These data indicate that OG1RF_10820-Tn (lytR), cscK-Tn, and OG1RF_12241-Tn (lysR) mutants restrict VPE25 DNA replication by increasing the phage latent period, resulting in reduced phage particle production.
Mutation of OG1RF_10820 (lytR) alters epa variable gene expression, negatively impacting phage infection.
To further assess the roles of the OG1RF_10820 (lytR), cscK, and OG1RF_12241 (lysR) genes during VPE25 infection, we performed phage adsorption assays with these strains. OG1RF_10820-Tn (lytR), which harbors a Tn-disrupted lytR response regulator gene, adsorbed 40% less phage than the wild-type control (Fig. 3A). Of the three Tn mutants, this was the only mutant that adsorbed less phage than the wild-type control. LytR type response regulators have been implicated in the biosynthesis of extracellular polysaccharides, including alginate biosynthesis in Pseudomonas aeruginosa (42, 46, 47). Since phage adsorption of E. faecalis is facilitated by Epa, we measured epa gene expression in the OG1RF_10820-Tn (lytR) background. The epa locus consists of core genes (epaA to epaR) that are conserved in E. faecalis, followed by a group of strain-specific variable genes that reside downstream of the core genes (37, 48). The expression of epa variable genes epaOX, epaOX2, and epaOY were reduced in the absence of OG1RF_10820 (lytR) during logarithmic and stationary-phase growth (Fig. 3B). In contrast, OG1RF_10820 (lytR) disruption did not alter the expression of core epa genes (see Fig. S3 in the supplemental material). Collectively, these results indicate that mutation of the lytR homolog hinders optimum binding of VPE25 by downregulating epa variable genes, thereby modifying the polysaccharide decoration of the core Epa structure (49).
Hypermutator strains defective in mismatch repair facilitate the acquisition of phage resistance in E. faecalis.
Transposon mutant OG1RF_12435-Tn, with an insertion in the DNA mismatch repair (MMR) gene mutS, was significantly overrepresented during VPE25 infection (Table S1; Fig. 1A). The MMR genes mutS and mutL correct replication-associated mismatch mutations (50). We discovered that VPE25-mediated lysis of the mutS-Tn-E (OG1RF_12435-Tn carrying the empty plasmid pAT28) and mutL-Tn-E (OG1RF_12434-Tn carrying the empty plasmid pAT28) mutants closely resembled wild-type lysis kinetics for ∼4 hours postinfection and released similar numbers of phage particles (Fig. 4A and B). However, these mutator strains eventually started to recover and escape infection, suggesting that the mutator phenotype gives rise to phage resistance (Fig. 4A). Introduction of the wild-type mutS and mutL genes cloned into plasmid pAT28 (mutS-Tn-C and mutL-Tn-C) restored the wild-type phage susceptibility phenotype (Fig. 4A). In the absence of phage, the wild-type, mutL-Tn, and mutS-Tn strains grew similarly, suggesting that hypermutator strains do not harbor growth defects in vitro (Fig. 4C).
To confirm that the mutS-Tn and mutL-Tn strains accumulate phage-resistant isolates during phage exposure, we performed phage infection assays using colonies of mutS-Tn and mutL-Tn grown overnight on agar plates in the absence and presence of VPE25. Consistent with our previous data, all mutS-Tn and mutL-Tn mutant colonies selected from agar plates lacking phage were initially phage sensitive, and over time became phage resistant (see Fig. S4A and C in the supplemental material). In contrast, the mutL-Tn and mutS-Tn colonies acquired from the phage-containing plates were phage resistant and had similar growth kinetics to the pipEF receptor mutant in the presence of VPE25 (Fig. S4A and C). All isolates grew similarly in the absence of phage (Fig. S4B and D). To gain insight into the basis of acquired phage resistance in the mismatch repair mutant backgrounds, we compared the phage adsorption profiles of the different strains. The mutL-Tn and mutS-Tn mutants that were not preexposed to VPE25 adsorbed phage at 70% to 80% efficiency, whereas mutL-Tn and mutS-Tn colonies chosen from phage-containing agar plates displayed a severe phage adsorption defect (Fig. S4E and F). Our data show that phage treatment leads to the selection and growth of phage adsorption-deficient isolates from mutL-Tn and mutS-Tn mutator cultures, most likely through mutations in epa variable genes. This also suggests that epa variable genes may be a hot spot for mutation in E. faecalis.
VPE25 infection drives global gene expression changes in E. faecalis.
To study temporal changes in E. faecalis gene expression during phage infection, we infected logarithmically growing E. faecalis with VPE25 at an MOI of 10. The cell density of infected E. faecalis cultures was comparable to the uninfected control cultures during the first 10 min of infection (Fig. 5A). Between 10 and 20 min postinfection, the VPE25 burst size increased as the cell density of the infected culture declined (Fig. 5A and B). VPE25 particle numbers plateaued 30 min postinfection, and there was no significant increase in phage output between 30 and 50 minutes of infection (Fig. 5B).
To investigate the transcriptional response of E. faecalis during VPE25 infection, we collected cells at several time points during distinct phases of the VPE25 infection cycle and performed RNA sequencing (RNA-Seq). Samples were collected at 10, 20, and 40 minutes postinfection, representing the early, middle, and late phase of the VPE25 infection cycle, respectively (Fig. 5A and B). Although phage replication peaks at 20 minutes, there is a modest reduction of the optical density at 600 nm (OD600) between 20 and 40 minutes, indicating that some cells in the culture may be more resistant to phage infection. Hierarchical clustering of differentially expressed E. faecalis genes during VPE25 infection compared with uninfected controls revealed unique gene expression patterns at each time point (Fig. 6A and B; Table S2B). Gene expression patterns grouped into three distinct clusters that correlated with the early, middle, and late stages of phage infection (Fig. 6A and B). Phages rely on host cell resources for the generation of viral progeny. Gene Ontology (GO) and KEGG enrichment analysis showed that phage infection influenced numerous E. faecalis metabolic pathways, including amino acid, carbohydrate, and nucleic acid metabolism (Table S2B).
Approximately 54% of the E. faecalis genome was differentially expressed (P < 0.05) relative to uninfected controls, with 692 downregulated and 731 upregulated genes over the course of phage infection (see Fig. S5A and C in the supplemental material). A total of 37 of the 692 downregulated genes were repressed throughout the course of phage infection and are broadly categorized as ribosome biogenesis and bacterial translation genes (Fig. S5B; Table S2C), indicating that VPE25 modulates host protein biogenesis to prevent bacterial growth and promote viral replication. In contrast, expression of 110 genes belonging to DNA repair pathways, amino acyl-tRNA biosynthesis, and carbohydrate metabolism were significantly upregulated throughout the phage infection cycle (Fig. S5D; Table S2D). The induction of DNA stress response genes suggests that E. faecalis cells activate DNA defense mechanisms to counteract phage-driven DNA damage.
Next, we assessed the transcriptome of VPE25 during infection. The VPE25 genome encodes 132 open reading frames (ORFs). We detected the differential expression of these ORFs by comparing the average read counts of individual genes at 10, 20, and 40 min relative to the start of infection (0 min). Hierarchical clustering grouped differentially expressed genes into early and late genes based on their distinct temporal expression patterns. The transcripts of 78 early genes, including those predicted to be involved in nucleotide biosynthesis and replication, accumulated during the first 10 min of infection (see Fig. S6A in the supplemental material; Table S2A). In contrast, late genes encoding phage structural components, DNA packaging, and host cell lysis were induced by 40 min of infection (Fig. S6A; Table S2A). Approximately 90 genes (68% of the VPE25 genome) annotated as hypothetical in the VPE25 genome were expressed during the early or late phase of infection (Fig. S6A; Table S2A), indicating that the majority of actively transcribed genes during VPE25 infection have no known function.
Phage infection modulates E. faecalis genes involved in group interactions.
Our transcriptomic data indicate that VPE25 infection causes a shift in the expression pattern of genes involved in pathways unrelated or peripheral to host metabolism and macromolecule biosynthesis (Fig. S5B and D). Most notably, we observed that phage infection led to a significant reduction in the expression of fsr quorum sensing genes and in the induction of type VII secretion system (T7SS) genes (Fig. S6B).
The E. faecalis fsr quorum sensing system is critical for virulence and biofilm formation in different animal models, including mouse models of endocarditis and peritonitis (51–55). The fsr quorum sensing system is comprised of the fsrA, fsrBD, and fsrC genes (56–58). fsrA encodes a response regulator that is constitutively expressed. fsrBD and fsrC encode the accessory protein, pheromone peptide, and the membrane histidine kinase required for functional quorum sensing-regulated gene expression in E. faecalis. Quantitative real-time PCR (qPCR) confirmed that fsrBD and fsrC are repressed throughout VPE25 infection, with the strength of repression increasing over time (Fig. 7A). There was a negligible impact on fsrA mRNA levels (Fig. 7A), consistent with its behavior as a constitutively expressed gene. qPCR analysis revealed several Fsr-controlled genes to be differentially expressed during phage infection. Fsr-dependent virulence factors, including gelE, sprE, OG1RF_10875 (EF1097), and OG1RF_10876 (EF1097b) genes (59), were all significantly downregulated during phage infection relative to uninfected controls (Fig. 7A and B). The fsr regulon is also an activator and repressor of several metabolic pathways (60). Our data demonstrate that the levels of Fsr-activated genes involved in the phosphotransferase sugar transport system (OG1RF_10296 and OG1RF_10297) are reduced, whereas negatively regulated genes in the fsr regulon, such as eutB, eutC, and eutH genes involved in ethanolamine utilization, are derepressed during VPE25 infection (Fig. 7B and C). These data suggest that VPE25 attenuates the FsrABDC system, consequently impacting E. faecalis virulence and metabolism.
Divergent forms of the T7SS (also known as the Ess/Esx system) are widely distributed in Gram-positive bacteria, and the T7SS has been extensively studied in the actinobacterium Mycobacterium tuberculosis (61–66). To date, enterococcal T7SS loci remain uncharacterized. Consistent with our transcriptomic data (Fig. S6B), we observed that phage infection induces genes in the E. faecalis T7SS locus, including OG1RF_11100 (esxA), OG1RF_11101 (essA), OG1RF_11104 (essB), OG1RF_11105 (essC1), OG1RF_11109, and OG1RF_11115 (essC2) (Fig. 7D). The esxA and OG1RF_11109 genes encode potential WXG100 domain-containing effector and LXG-domain toxin proteins, respectively. The secretion of T7SS factors is dependent on the EssB transmembrane protein and FtsK/SpoIIIE ATPases encoded by the essC1 and essC2 genes. The T7SS in Gram-positive bacteria is involved in immune system activation, apoptosis of mammalian cells, bacterial cell development and lysis, DNA transfer, and bacterial interspecies interactions (62, 67–77).
Similar to other phage-bacterium interaction studies (26, 28–30, 78), we investigated the transcriptional response of E. faecalis during VPE25 infection using a high MOI (MOI, 10) to increase the probability of phage infection and minimize transcriptional noise from uninfected bacterial cells. However, a lower MOI (MOI, 1) is sufficient to alter the expression profile of at least a subset of quorum sensing and T7SS genes (Fig. S6C). Additionally, administration of VPE25 (MOI, 10) to the phage-resistant E. faecalis strain ΔpipEF did not alter mRNA levels of fsr quorum sensing or T7SS genes (Fig. S6D), suggesting that successful phage infection is essential to modulate the expression of these bacterial genes. To investigate whether phage-mediated expression of fsrABDC and the T7SS genes are VPE25 specific, we examined the expression patterns of a subset of these genes in E. faecalis when infected with the PipEF-independent lytic phage NPV-1, which shares little genetic similarity to phage VPE25 (2.4% pairwise nucleotide identity across its genome). mRNA levels of fsrB and sprE were reduced, whereas expression of the T7SS genes were elevated during NPV-1 infection (Fig. S6E), suggesting that phage-specific control of quorum sensing and T7SS expression are not restricted to VPE25 infection. Together, these findings indicate that phage infection of E. faecalis has the potential to influence bacterial adaptation in polymicrobial communities or during mixed bacterial species infections.
DISCUSSION
Characterizing bacterial responses to phage infection is important for understanding how phages modulate bacterial physiology and will inform approaches toward effective phage therapies against MDR bacteria. Commonly used approaches to identify phage-resistant bacteria often yield information restricted to phage receptors and/or adsorption mechanisms. While useful, these approaches often overlook more subtle interactions that drive the efficiency of phage infection and phage particle biogenesis. Additionally, these approaches provide minimal information on how bacteria sense and respond to phage infection. These are important gaps in knowledge considering the heightened interest in utilizing phages as clinical therapeutics against difficult-to-treat bacterial infections. To begin to address these knowledge gaps we have studied the model Gram-positive commensal and opportunistic pathogen E. faecalis when infected with its cognate lytic phage VPE25. We have discovered several novel bacterial factors that are indispensable for efficient VPE25 infection of E. faecalis. In addition, we have uncovered key insights into the molecular events that are triggered in E. faecalis cells during phage infection. Importantly, our work shows that E. faecalis alters the expression of genes associated with environmental sensing and group interactions during phage infection. Such a response may have unexpected consequences in polymicrobial communities, and our work sets the stage for studying how phage therapies may impact nontarget bacteria in the microbiota.
Tn-Seq identified numerous E. faecalis genes that govern VPE25 susceptibility. Mutations in epa variable genes conferred VPE25 resistance by preventing phage adsorption, similar to other E. faecalis phages (23, 35–37). We discovered that phage infection of mismatch repair gene mutants results in the emergence of phage adsorption deficiencies; thus, the mismatch repair system likely fails to correct DNA damage of epa genes during phage infection. This suggests that epa genes may be a hot spot for mutation. Tn-Seq also enabled the discovery of the LytR-domain transcription factor encoded by OG1RF_10820 (lytR) as a regulator of epa variable locus gene expression (Fig. 3B). Considering an epa mutant strain of E. faecalis is defective in colonization and outgrowth during antibiotic selection in the intestine (23), we believe that future investigation of LytR-mediated regulation of epa and potentially other genomic loci could guide the development of effective therapeutics to control E. faecalis colonization and infections.
In this work, we have discovered bacterial metabolic and oxidative stress response genes that are important for phage infection. Decreased phage replication coupled with lower burst size of VPE25 in the fructose kinase mutant (cscK) suggests that VPE25 relies on host carbohydrate metabolism to support viral progeny formation. The reliance of VPE25 on host CscK for viral propagation is corroborated by RNA-Seq data showing broad induction of bacterial host carbohydrate metabolism genes during VPE25 infection. Furthermore, we observed that VPE25 lytic growth leads to a gradual rise in the OG1RF_12241 (lysR) transcripts which encode the LysR homolog HypR, a regulator of oxidative stress. Phage infection enhanced the transcript levels of three other oxidative stress response genes, including OG1RF_10348, OG1RF_10983, and OG1RF_11314 encoding superoxide dismutase (sodA), NADH peroxidase (npr), and catalase (katA), respectively (Table S2B). In Campylobacter jejuni, mutations in the LysR-regulated gene ahpC, as well as sodB and katA, resulted in reduced plaquing efficiency by the phage NCTC 12673 (27). We hypothesize that phage tolerance during hypersensitivity to oxidative stress could be detrimental to E. faecalis and targeting such pathways could be used to control E. faecalis colonization.
Our data indicate that putative T7SS genes are activated in response to phage infection. Although E. faecalis T7SS remains poorly characterized, the Staphylococcus aureus T7 system has been demonstrated to defend cells against neutrophil assault and enhance epithelial cell apoptosis and is critical for virulence (68, 69, 79, 80). Additionally, S. aureus T7SS maintains membrane homeostasis and is involved in the membrane stress response (69, 81). The finding that E. faecalis T7SS genes are induced in response to two different phages suggests phage-mediated membrane damage may lead to elevated T7SS gene expression. Finally, the S. aureus T7SS nuclease toxin EsaD contributes to interspecies competition through growth inhibition of rival strains lacking the EsaG antitoxin (77). The impact of S. aureus T7SS on rival strains and the presence of T7SS genes in environmental isolates (82, 83) suggest a pivotal role of this secretion system in shaping microbial communities.
In contrast to the T7SS, the bacterial population-associated quorum sensing fsr locus was repressed during VPE25 infection in E. faecalis. Gram-negative bacteria can escape phage invasion by quorum sensing-mediated downregulation of phage receptor expression or activation of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas immunity (84–87). The fsr regulon does not include the receptor (pipEF), epa genes necessary for phage adsorption, or CRISPR-Cas. However, the fsr system does contribute to biofilm formation that could potentially deter phage infection (55, 88). VPE25 infection may attenuate fsr-mediated biofilm formation to favor the continued infection of neighboring planktonic cells. On the other hand, phage genomes have been shown to carry enzymes that degrade quorum sensing molecules or anti-CRISPR genes to evade host defense strategies (89, 90). Although such anti-host accessory genes are not evident in the VPE25 genome, it is possible that phage-carrying hypothetical genes influence E. faecalis quorum sensing and dictate molecular events that favor phage production.
Integration of global transcriptomics and transposon library screening of VPE25-infected E. faecalis has revealed new insights into our understanding of phage-host interactions in enterococci. Together, our results emphasize the importance of epa gene regulation, carbohydrate metabolism, and the oxidative stress response in successful phage predation. Furthermore, contributions of VPE25 on E. faecalis fsr and T7SS genes involved in inter- and intrabacterial interactions suggest that phage therapy could impact microbial community dynamics in patients undergoing treatment, and such an outcome should be considered for the development of phage-based therapeutics.
MATERIALS AND METHODS
Bacteria and bacteriophages.
All bacteria and phages used in this study are listed in Table S3 in the supplemental material. E. faecalis strains were grown with aeration on Todd-Hewitt broth (THB) or THB agar at 37°C. Escherichia coli was grown on Lennox L broth (LB) with aeration or on LB agar at 37°C. The following antibiotic concentrations were added to media for selection of E. coli or E. faecalis: 25 μg/ml fusidic acid, 50 μg/ml rifampin, 750 μg/ml spectinomycin, and 20 μg/ml chloramphenicol. Phage sensitivity assays were performed on THB agar supplemented with 10 mM MgSO4. Phages used for all experiments were purified by cesium chloride gradient separation as described previously (32).
Transposon library screen.
A total of 108 CFUs of the E. faecalis OG1RF pooled transposon library was inoculated into 5 ml of THB and grown with aeration to an optical density of 600 nm (OD600) of 0.5. A total of 107 CFUs of the library was spread onto a THB agar plate (10 replicates) containing 10 mM MgSO4 in the absence and presence of 106 PFUs of VPE25 (MOI, 0.1). After overnight (O/N) incubation at 37°C, bacterial growth from the control and phage-containing plates was resuspended in 5 ml of phosphate-buffered saline (PBS). Genomic DNA was isolated from the input library and from three biological replicates of phage-exposed and unexposed samples using a ZymoBIOMICS DNA miniprep kit (Zymo Research), following the manufacturers protocol.
Phage sensitivity and burst kinetic assays.
O/N cultures of E. faecalis were subcultured to a starting OD600 of 0.025 in 25 ml of THB. When the bacterial culture reached mid-logarithmic phase (OD600, ∼0.5), 10 mM MgSO4 and VPE25 (MOI of 0.1 or 10) were added. OD600 was monitored for ∼7 h. To investigate if phage progeny were produced and released from the bacterial cells upon VPE25 infection, 250 μl of culture was collected at different time points over the course of infection and thoroughly mixed with 1/3 volume of chloroform. The aqueous phase-containing phages was separated from the chloroform by centrifugation at 24,000 × g for 1 min, and the phage titer was determined using a THB agar overlay plaque assay. Data are presented as the average of three replicates with +/− standard deviation.
Phage infection time course.
O/N cultures of E. faecalis were subcultured to a starting OD600 of 0.025 in 50 ml of THB. When the bacterial culture reached mid-logarithmic phase (OD600, ∼0.5), 10 mM MgSO4 and VPE25 (MOI of 10) were added. A total of 4 ml of cell suspension was pelleted from the uninfected and infected cultures after 0, 10, 20, and 40 minutes after VPE25 treatment. The pellets were washed with 4 ml of PBS three times, followed by a wash with 2 ml RNAlater (Invitrogen), and RNA isolation was performed as described above.
Further experimental details can be found in the supplemental Materials and Methods (Text S1).
Data availability.
The RNA-Seq reads associated with this study have been deposited at the ArrayExpress database at EMBL-EBI under accession number E-MTAB-8546. Tn-Seq reads have been deposited at the European Nucleotide Archive under accession number PRJEB35492.
ACKNOWLEDGMENTS
This work was supported by National Institutes of Health grants R01AI141479 (B.A.D.), R01AI122742 (G.M.D.), and R01AI116610 (K.L.P.). J.L.E.W. was supported by American Heart Association grant 19POST34450124/Julia Willett/2018.
We thank Katrina Diener and Monica Ransom from the University of Colorado Anschutz Medical Campus Genomics and Microarray Core for the development of a customized Tn-Seq library preparation protocol. We thank Stefan Pukatzki and Pukatzki lab members for sharing their qPCR machine.
Footnotes
Citation Chatterjee A, Willett JLE, Nguyen UT, Monogue B, Palmer KL, Dunny GM, Duerkop BA. 2020. Parallel genomics uncover novel enterococcal-bacteriophage interactions. mBio 11:e03120-19. https://doi.org/10.1128/mBio.03120-19.
REFERENCES
- 1.Lebreton F, Willems RJL, Gilmore MS. 2014. Enterococcus diversity, origins in nature, and gut colonization In Gilmore MS, Clewell DB, Ike Y, Shankar N (ed), Enterococci: from commensals to leading causes of drug resistant infection. Massachusetts Eye and Eat Infirmary, Boston, MA. [PubMed] [Google Scholar]
- 2.Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK, National Healthcare Safety Network T, Participating National Healthcare Safety Network Facilities. 2008. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29:996–1011. doi: 10.1086/591861. [DOI] [PubMed] [Google Scholar]
- 3.Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL. 1976. Microbial synergy in experimental intra-abdominal abscess. Infect Immun 13:22–26. doi: 10.1128/IAI.13.1.22-26.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Al-Nassir WN, Sethi AK, Li Y, Pultz MJ, Riggs MM, Donskey CJ. 2008. Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother 52:2403–2406. doi: 10.1128/AAC.00090-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND, van den Brink MR, Kamboj M, Pamer EG. 2010. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120:4332–4341. doi: 10.1172/JCI43918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zirakzadeh A, Patel R. 2006. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc 81:529–536. doi: 10.4065/81.4.529. [DOI] [PubMed] [Google Scholar]
- 7.Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, Diaz L, Tran TT, Rincon S, Barbu EM, Reyes J, Roh JH, Lobos E, Sodergren E, Pasqualini R, Arap W, Quinn JP, Shamoo Y, Murray BE, Weinstock GM. 2011. Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 365:892–900. doi: 10.1056/NEJMoa1011138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Liu Y, Wang Y, Wu C, Shen Z, Schwarz S, Du X-D, Dai L, Zhang W, Zhang Q, Shen J. 2012. First report of the multidrug resistance gene cfr in Enterococcus faecalis of animal origin. Antimicrob Agents Chemother 56:1650–1654. doi: 10.1128/AAC.06091-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Munoz-Price LS, Lolans K, Quinn JP. 2005. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin Infect Dis 41:565–566. doi: 10.1086/432121. [DOI] [PubMed] [Google Scholar]
- 10.Patel SN, Memari N, Shahinas D, Toye B, Jamieson FB, Farrell DJ. 2013. Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada. Diagn Microbiol Infect Dis 77:350–353. doi: 10.1016/j.diagmicrobio.2013.08.012. [DOI] [PubMed] [Google Scholar]
- 11.Palmer KL, Kos VN, Gilmore MS. 2010. Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr Opin Microbiol 13:632–639. doi: 10.1016/j.mib.2010.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kurenbach B, Bohn C, Prabhu J, Abudukerim M, Szewzyk U, Grohmann E. 2003. Intergeneric transfer of the Enterococcus faecalis plasmid pIP501 to Escherichia coli and Streptomyces lividans and sequence analysis of its tra region. Plasmid 50:86–93. doi: 10.1016/s0147-619x(03)00044-1. [DOI] [PubMed] [Google Scholar]
- 13.Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK, Vancomycin-Resistant Staphylococcus aureus Investigative Team. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348:1342–1347. doi: 10.1056/NEJMoa025025. [DOI] [PubMed] [Google Scholar]
- 14.Vicente MF, Baquero F, Pérez-Díaz JC. 1988. Conjugative acquisition and expression of antibiotic resistance determinants in Listeria spp. J Antimicrob Chemother 21:309–318. doi: 10.1093/jac/21.3.309. [DOI] [PubMed] [Google Scholar]
- 15.Pucci MJ, Monteschio ME, Kemker CL. 1988. Intergeneric and intrageneric conjugal transfer of plasmid-encoded antibiotic resistance determinants in Leuconostoc spp. Appl Environ Microbiol 54:281–287. doi: 10.1128/AEM.54.2.281-287.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jasni AS, Mullany P, Hussain H, Roberts AP. 2010. Demonstration of conjugative transposon (Tn5397)-mediated horizontal gene transfer between Clostridium difficile and Enterococcus faecalis. Antimicrob Agents Chemother 54:4924–4926. doi: 10.1128/AAC.00496-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC. 2003. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569–1571. doi: 10.1126/science.1090956. [DOI] [PubMed] [Google Scholar]
- 18.Khalifa L, Brosh Y, Gelman D, Coppenhagen-Glazer S, Beyth S, Poradosu-Cohen R, Que YA, Beyth N, Hazan R. 2015. Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol 81:2696–2705. doi: 10.1128/AEM.00096-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, Carlton R, Merril CR. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect Immun 70:204–210. doi: 10.1128/iai.70.1.204-210.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhang W, Mi Z, Yin X, Fan H, An X, Zhang Z, Chen J, Tong Y. 2013. Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin. PLoS One 8:e80435. doi: 10.1371/journal.pone.0080435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Melo LDR, Ferreira R, Costa AR, Oliveira H, Azeredo J. 2019. Efficacy and safety assessment of two enterococci phages in an in vitro biofilm wound model. Sci Rep 9:6643. doi: 10.1038/s41598-019-43115-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Al-Zubidi M, Widziolek M, Court EK, Gains AF, Smith RE, Ansbro K, Alrafaie A, Evans C, Murdoch C, Mesnage S, Douglas CWI, Rawlinson A, Stafford GP. 2019. Identification of novel bacteriophages with therapeutic potential that target Enterococcus faecalis. Infect Immun 87:e00512-19. doi: 10.1128/IAI.00512-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Chatterjee A, Johnson CN, Luong P, Hullahalli K, McBride SW, Schubert AM, Palmer KL, Carlson PE Jr., Duerkop BA. 2019. Bacteriophage resistance alters antibiotic-mediated intestinal expansion of enterococci. Infect Immun 87:e00085-19. doi: 10.1128/IAI.00085-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B. 2015. Bacteriophages and phage-derived proteins-application approaches. Curr Med Chem 22:1757–1773. doi: 10.2174/0929867322666150209152851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Warwick-Dugdale J, Buchholz HH, Allen MJ, Temperton B. 2019. Host-hijacking and planktonic piracy: how phages command the microbial high seas. Virol J 16:15. doi: 10.1186/s12985-019-1120-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Yang Z, Yin S, Li G, Wang J, Huang G, Jiang B, You B, Gong Y, Zhang C, Luo X, Peng Y, Zhao X. 2019. Global transcriptomic analysis of the interactions between phage phiAbp1 and extensively drug-resistant Acinetobacter baumannii. mSystems 4:e00068-19. doi: 10.1128/mSystems.00068-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sacher JC, Flint A, Butcher J, Blasdel B, Reynolds HM, Lavigne R, Stintzi A, Szymanski CM. 2018. Transcriptomic analysis of the Campylobacter jejuni response to T4-like phage NCTC 12673 infection. Viruses 10:332. doi: 10.3390/v10060332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mojardin L, Salas M. 2016. Global transcriptional analysis of virus-host interactions between phage ϕphi29 and Bacillus subtilis. J Virol 90:9293–9304. doi: 10.1128/JVI.01245-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Leskinen K, Blasdel BG, Lavigne R, Skurnik M. 2016. RNA-sequencing reveals the progression of phage-host interactions between phiR1-37 and Yersinia enterocolitica. Viruses 8:111. doi: 10.3390/v8040111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Chevallereau A, Blasdel BG, De Smet J, Monot M, Zimmermann M, Kogadeeva M, Sauer U, Jorth P, Whiteley M, Debarbieux L, Lavigne R. 2016. Next-generation “-omics” approaches reveal a massive alteration of host RNA metabolism during bacteriophage infection of Pseudomonas aeruginosa. PLoS Genet 12:e1006134. doi: 10.1371/journal.pgen.1006134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Jorth P, Trivedi U, Rumbaugh K, Whiteley M. 2013. Probing bacterial metabolism during infection using high-resolution transcriptomics. J Bacteriol 195:4991–4998. doi: 10.1128/JB.00875-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Duerkop BA, Huo W, Bhardwaj P, Palmer KL, Hooper LV. 2016. Molecular basis for lytic bacteriophage resistance in enterococci. mBio 7:e01304-16. doi: 10.1128/mBio.01304-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Dale JL, Beckman KB, Willett JLE, Nilson JL, Palani NP, Baller JA, Hauge A, Gohl DM, Erickson R, Manias DA, Sadowsky MJ, Dunny GM. 2018. Comprehensive functional analysis of the Enterococcus faecalis core genome using an ordered, sequence-defined collection of insertional mutations in strain OG1RF. mSystems 3:e00062-18. doi: 10.1128/mSystems.00062-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Xu Y, Murray BE, Weinstock GM. 1998. A cluster of genes involved in polysaccharide biosynthesis from Enterococcus faecalis OG1RF. Infect Immun 66:4313–4323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Ho K, Huo W, Pas S, Dao R, Palmer KL. 2018. Loss-of-function mutations in epaR confer resistance to ϕNPV1 infection in Enterococcus faecalis OG1RF. Antimicrob Agents Chemother 62:e00758-18. doi: 10.1128/AAC.00758-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lossouarn J, Briet A, Moncaut E, Furlan S, Bouteau A, Son O, Leroy M, DuBow MS, Lecointe F, Serror P, Petit MA. 2019. Enterococcus faecalis countermeasures defeat a virulent Picovirinae bacteriophage. Viruses 11:48. doi: 10.3390/v11010048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Teng F, Singh KV, Bourgogne A, Zeng J, Murray BE. 2009. Further characterization of the epa gene cluster and Epa polysaccharides of Enterococcus faecalis. Infect Immun 77:3759–3767. doi: 10.1128/IAI.00149-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Dale JL, Cagnazzo J, Phan CQ, Barnes AM, Dunny GM. 2015. Multiple roles for Enterococcus faecalis glycosyltransferases in biofilm-associated antibiotic resistance, cell envelope integrity, and conjugative transfer. Antimicrob Agents Chemother 59:4094–4105. doi: 10.1128/AAC.00344-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Baptista C, Santos MA, São-José C. 2008. Phage SPP1 reversible adsorption to Bacillus subtilis cell wall teichoic acids accelerates virus recognition of membrane receptor YueB. J Bacteriol 190:4989–4996. doi: 10.1128/JB.00349-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Monteville MR, Ardestani B, Geller BL. 1994. Lactococcal bacteriophages require a host cell wall carbohydrate and a plasma membrane protein for adsorption and ejection of DNA. Appl Environ Microbiol 60:3204–3211. doi: 10.1128/AEM.60.9.3204-3211.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.São-José C, Baptista C, Santos MA. 2004. Bacillus subtilis operon encoding a membrane receptor for bacteriophage SPP1. J Bacteriol 186:8337–8346. doi: 10.1128/JB.186.24.8337-8346.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Nikolskaya AN, Galperin MY. 2002. A novel type of conserved DNA-binding domain in the transcriptional regulators of the AlgR/AgrA/LytR family. Nucleic Acids Res 30:2453–2459. doi: 10.1093/nar/30.11.2453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Verneuil N, Sanguinetti M, Le Breton Y, Posteraro B, Fadda G, Auffray Y, Hartke A, Giard J-C. 2004. Effects of the Enterococcus faecalis hypR gene encoding a new transcriptional regulator on oxidative stress response and intracellular survival within macrophages. Infect Immun 72:4424–4431. doi: 10.1128/IAI.72.8.4424-4431.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.La Carbona S, Sauvageot N, Giard JC, Benachour A, Posteraro B, Auffray Y, Sanguinetti M, Hartke A. 2007. Comparative study of the physiological roles of three peroxidases (NADH peroxidase, alkyl hydroperoxide reductase and thiol peroxidase) in oxidative stress response, survival inside macrophages and virulence of Enterococcus faecalis. Mol Microbiol 66:1148–1163. doi: 10.1111/j.1365-2958.2007.05987.x. [DOI] [PubMed] [Google Scholar]
- 45.Sabri S, Nielsen LK, Vickers CE. 2013. Molecular control of sucrose utilization in Escherichia coli W, an efficient sucrose-utilizing strain. Appl Environ Microbiol 79:478–487. doi: 10.1128/AEM.02544-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Mohr CD, Leveau JH, Krieg DP, Hibler NS, Deretic V. 1992. AlgR-binding sites within the algD promoter make up a set of inverted repeats separated by a large intervening segment of DNA. J Bacteriol 174:6624–6633. doi: 10.1128/jb.174.20.6624-6633.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Mohr CD, Hibler NS, Deretic V. 1991. AlgR, a response regulator controlling mucoidy in Pseudomonas aeruginosa, binds to the FUS sites of the algD promoter located unusually far upstream from the mRNA start site. J Bacteriol 173:5136–5143. doi: 10.1128/jb.173.16.5136-5143.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Palmer KL, Godfrey P, Griggs A, Kos VN, Zucker J, Desjardins C, Cerqueira G, Gevers D, Walker S, Wortman J, Feldgarden M, Haas B, Birren B, Gilmore MS. 2012. Comparative genomics of enterococci: variation in Enterococcus faecalis, clade structure in E. faecium, and defining characteristics of E. gallinarum and E. casseliflavus. mBio 3:e00318-11. doi: 10.1128/mBio.00318-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Smith RE, Salamaga B, Szkuta P, Hajdamowicz N, Prajsnar TK, Bulmer GS, Fontaine T, Kołodziejczyk J, Herry J-M, Hounslow AM, Williamson MP, Serror P, Mesnage S. 2019. Decoration of the enterococcal polysaccharide antigen EPA is essential for virulence, cell surface charge and interaction with effectors of the innate immune system. PLoS Pathog 15:e1007730. doi: 10.1371/journal.ppat.1007730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kunkel TA, Erie DA. 2005. DNA mismatch repair. Annu Rev Biochem 74:681–710. doi: 10.1146/annurev.biochem.74.082803.133243. [DOI] [PubMed] [Google Scholar]
- 51.Singh KV, Nallapareddy SR, Nannini EC, Murray BE. 2005. Fsr-independent production of protease(s) may explain the lack of attenuation of an Enterococcus faecalis fsr mutant versus a gelE-sprE mutant in induction of endocarditis. Infect Immun 73:4888–4894. doi: 10.1128/IAI.73.8.4888-4894.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Qin X, Singh KV, Weinstock GM, Murray BE. 2000. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect Immun 68:2579–2586. doi: 10.1128/iai.68.5.2579-2586.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Mohamed JA, Huang W, Nallapareddy SR, Teng F, Murray BE. 2004. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect Immun 72:3658–3663. doi: 10.1128/IAI.72.6.3658-3663.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hufnagel M, Koch S, Creti R, Baldassarri L, Huebner J. 2004. A putative sugar-binding transcriptional regulator in a novel gene locus in Enterococcus faecalis contributes to production of biofilm and prolonged bacteremia in mice. J Infect Dis 189:420–430. doi: 10.1086/381150. [DOI] [PubMed] [Google Scholar]
- 55.Hancock LE, Perego M. 2004. The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J Bacteriol 186:5629–5639. doi: 10.1128/JB.186.17.5629-5639.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Nakayama J, Chen S, Oyama N, Nishiguchi K, Azab EA, Tanaka E, Kariyama R, Sonomoto K. 2006. Revised model for Enterococcus faecalis fsr quorum-sensing system: the small open reading frame fsrD encodes the gelatinase biosynthesis-activating pheromone propeptide corresponding to staphylococcal agrD. J Bacteriol 188:8321–8326. doi: 10.1128/JB.00865-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Qin X, Singh KV, Weinstock GM, Murray BE. 2001. Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF. J Bacteriol 183:3372–3382. doi: 10.1128/JB.183.11.3372-3382.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Nakayama J, Cao Y, Horii T, Sakuda S, Akkermans AD, de Vos WM, Nagasawa H. 2001. Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis. Mol Microbiol 41:145–154. doi: 10.1046/j.1365-2958.2001.02486.x. [DOI] [PubMed] [Google Scholar]
- 59.Del Papa MF, Perego M. 2011. Enterococcus faecalis virulence regulator FsrA binding to target promoters. J Bacteriol 193:1527–1532. doi: 10.1128/JB.01522-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Bourgogne A, Hilsenbeck SG, Dunny GM, Murray BE. 2006. Comparison of OG1RF and an isogenic fsrB deletion mutant by transcriptional analysis: the Fsr system of Enterococcus faecalis is more than the activator of gelatinase and serine protease. J Bacteriol 188:2875–2884. doi: 10.1128/JB.188.8.2875-2884.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Abdallah AM, Gey van Pittius NC, Champion PA, Cox J, Luirink J, Vandenbroucke-Grauls CM, Appelmelk BJ, Bitter W. 2007. Type VII secretion-mycobacteria show the way. Nat Rev Microbiol 5:883–891. doi: 10.1038/nrmicro1773. [DOI] [PubMed] [Google Scholar]
- 62.Stanley SA, Raghavan S, Hwang WW, Cox JS. 2003. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A 100:13001–13006. doi: 10.1073/pnas.2235593100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, Griffiths KE, Marchal G, Leclerc C, Cole ST. 2003. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9:533–539. doi: 10.1038/nm859. [DOI] [PubMed] [Google Scholar]
- 64.Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, Behr MA, Sherman DR. 2003. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. J Infect Dis 187:117–123. doi: 10.1086/345862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Pallen MJ. 2002. The ESAT-6/WXG100 superfamily—and a new Gram-positive secretion system? Trends Microbiol 10:209–212. doi: 10.1016/S0966-842X(02)02345-4. [DOI] [PubMed] [Google Scholar]
- 66.Gey Van Pittius NC, Gamieldien J, Hide W, Brown GD, Siezen RJ, Beyers AD. 2001. The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol 2:research0044. doi: 10.1186/gb-2001-2-10-research0044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Whitney JC, Peterson SB, Kim J, Pazos M, Verster AJ, Radey MC, Kulasekara HD, Ching MQ, Bullen NP, Bryant D, Goo YA, Surette MG, Borenstein E, Vollmer W, Mougous JD. 2017. A broadly distributed toxin family mediates contact-dependent antagonism between gram-positive bacteria. Elife 6:e26938. doi: 10.7554/eLife.26938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Korea CG, Balsamo G, Pezzicoli A, Merakou C, Tavarini S, Bagnoli F, Serruto D, Unnikrishnan M. 2014. Staphylococcal Esx proteins modulate apoptosis and release of intracellular Staphylococcus aureus during infection in epithelial cells. Infect Immun 82:4144–4153. doi: 10.1128/IAI.01576-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Kneuper H, Cao ZP, Twomey KB, Zoltner M, Jager F, Cargill JS, Chalmers J, van der Kooi-Pol MM, van Dijl JM, Ryan RP, Hunter WN, Palmer T. 2014. Heterogeneity in ess transcriptional organization and variable contribution of the Ess/Type VII protein secretion system to virulence across closely related Staphylocccus aureus strains. Mol Microbiol 93:928–943. doi: 10.1111/mmi.12707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Aguilo JI, Alonso H, Uranga S, Marinova D, Arbues A, de Martino A, Anel A, Monzon M, Badiola J, Pardo J, Brosch R, Martin C. 2013. ESX-1-induced apoptosis is involved in cell-to-cell spread of Mycobacterium tuberculosis. Cell Microbiol 15:1994–2005. doi: 10.1111/cmi.12169. [DOI] [PubMed] [Google Scholar]
- 71.Burts ML, DeDent AC, Missiakas DM. 2008. EsaC substrate for the ESAT-6 secretion pathway and its role in persistent infections of Staphylococcus aureus. Mol Microbiol 69:736–746. doi: 10.1111/j.1365-2958.2008.06324.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Stanley SA, Johndrow JE, Manzanillo P, Cox JS. 2007. The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J Immunol 178:3143–3152. doi: 10.4049/jimmunol.178.5.3143. [DOI] [PubMed] [Google Scholar]
- 73.Brodin P, Majlessi L, Marsollier L, de Jonge MI, Bottai D, Demangel C, Hinds J, Neyrolles O, Butcher PD, Leclerc C, Cole ST, Brosch R. 2006. Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun 74:88–98. doi: 10.1128/IAI.74.1.88-98.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Guinn KM, Hickey MJ, Mathur SK, Zakel KL, Grotzke JE, Lewinsohn DM, Smith S, Sherman DR. 2004. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol 51:359–370. doi: 10.1046/j.1365-2958.2003.03844.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Flint JL, Kowalski JC, Karnati PK, Derbyshire KM. 2004. The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis. Proc Natl Acad Sci U S A 101:12598–12603. doi: 10.1073/pnas.0404892101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, Morin PM, Marks CB, Padiyar J, Goulding C, Gingery M, Eisenberg D, Russell RG, Derrick SC, Collins FM, Morris SL, King CH, Jacobs WR Jr., 2003. The primary mechanism of attenuation of bacillus Calmette-Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A 100:12420–12425. doi: 10.1073/pnas.1635213100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Cao Z, Casabona MG, Kneuper H, Chalmers JD, Palmer T. 2016. The type VII secretion system of Staphylococcus aureus secretes a nuclease toxin that targets competitor bacteria. Nat Microbiol 2:16183. doi: 10.1038/nmicrobiol.2016.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Blasdel BG, Chevallereau A, Monot M, Lavigne R, Debarbieux L. 2017. Comparative transcriptomics analyses reveal the conservation of an ancestral infectious strategy in two bacteriophage genera. ISME J 11:1988–1996. doi: 10.1038/ismej.2017.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Wang Y, Hu M, Liu Q, Qin J, Dai Y, He L, Li T, Zheng B, Zhou F, Yu K, Fang J, Liu X, Otto M, Li M. 2016. Role of the ESAT-6 secretion system in virulence of the emerging community-associated Staphylococcus aureus lineage ST398. Sci Rep 6:25163. doi: 10.1038/srep25163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Burts ML, Williams WA, DeBord K, Missiakas DM. 2005. EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections. Proc Natl Acad Sci U S A 102:1169–1174. doi: 10.1073/pnas.0405620102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Casabona MG, Buchanan G, Zoltner M, Harkins CP, Holden MTG, Palmer T. 2017. Functional analysis of the EsaB component of the Staphylococcus aureus Type VII secretion system. Microbiology 163:1851–1863. doi: 10.1099/mic.0.000580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Baptista C, Barreto HC, São-José C. 2013. High levels of DegU-P activate an Esat-6-like secretion system in Bacillus subtilis. PLoS One 8:e67840. doi: 10.1371/journal.pone.0067840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Akpe San Roman S, Facey PD, Fernandez-Martinez L, Rodriguez C, Vallin C, Del Sol R, Dyson P. 2010. A heterodimer of EsxA and EsxB is involved in sporulation and is secreted by a type VII secretion system in Streptomyces coelicolor. Microbiology 156:1719–1729. doi: 10.1099/mic.0.037069-0. [DOI] [PubMed] [Google Scholar]
- 84.Høyland-Kroghsbo NM, Paczkowski J, Mukherjee S, Broniewski J, Westra E, Bondy-Denomy J, Bassler BL. 2017. Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system. Proc Natl Acad Sci U S A 114:131–135. doi: 10.1073/pnas.1617415113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Patterson AG, Jackson SA, Taylor C, Evans GB, Salmond GPC, Przybilski R, Staals RHJ, Fineran PC. 2016. Quorum sensing controls adaptive immunity through the regulation of multiple CRISPR-Cas systems. Mol Cell 64:1102–1108. doi: 10.1016/j.molcel.2016.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Tan D, Svenningsen SL, Middelboe M. 2015. Quorum sensing determines the choice of antiphage defense strategy in Vibrio anguillarum. mBio 6:e00627-15. doi: 10.1128/mBio.00627-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Høyland-Kroghsbo NM, Maerkedahl RB, Svenningsen SL. 2013. A quorum-sensing-induced bacteriophage defense mechanism. mBio 4:e00362-12. doi: 10.1128/mBio.00362-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Abedon ST. 2017. Phage “delay” towards enhancing bacterial escape from biofilms: a more comprehensive way of viewing resistance to bacteriophages. AIMS Microbiol 3:186–226. doi: 10.3934/microbiol.2017.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Hargreaves KR, Kropinski AM, Clokie MRJ. 2014. Bacteriophage behavioral ecology: how phages alter their bacterial host’s habits. Bacteriophage 4:e29866. doi: 10.4161/bact.29866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR. 2013. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493:429–432. doi: 10.1038/nature11723. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The RNA-Seq reads associated with this study have been deposited at the ArrayExpress database at EMBL-EBI under accession number E-MTAB-8546. Tn-Seq reads have been deposited at the European Nucleotide Archive under accession number PRJEB35492.